A detailed history of Corton Capital Inc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 12,322 shares of FLGT stock, worth $219,208. This represents 0.14% of its overall portfolio holdings.

Number of Shares
12,322
Holding current value
$219,208
% of portfolio
0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $241,511 - $308,789
12,322 New
12,322 $267,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $230,277 - $294,860
9,741 New
9,741 $281,000
Q2 2022

Aug 15, 2022

SELL
$47.98 - $62.75 $162,076 - $211,969
-3,378 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $168,393 - $324,659
3,378 New
3,378 $211,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $538M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.